Project Details
Projekt Print View

The role of the Interleukin-6 receptor in liver damage and regeneration

Subject Area Gastroenterology
Immunology
Term from 2020 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 446322183
 
Final Report Year 2024

Final Report Abstract

The interplay between the immune response and liver damage/regeneration is controlled by the interleukin (IL)-6 family of cytokines. IL-6 is directly involved in liver regeneration. To signal, IL-6 bind to the non-signal transducing IL-6 receptor (IL-6R) followed by Director complex formation with the signal transducing glycoprotein 130 (gp130) receptor. IL-6 deficient mice show a decelerated liver regeneration Carmen Auweiler-Niesen accompanied by increased mortality following partial hepatectomy (PHX). Previously, we showed that IL-6 trans-signalling controls hepatocyte proliferation and thus liver regeneration after PHX via direct and indirect mechanisms. Here, we addressed three main objectives and 1. identified hepatocytes as main target cells for IL-6 type cytokines, 2. rescued the PHX regeneration defect of IL-6R deficient mice by IL-6 type cytokines and 3. showed that constitutive active gp130 signaling restricted to hepatocytes did not rescue the PHX regeneration defect of IL-6R deficient mice. Additionally, in co-operation with the local Düsseldorf group of Prof. E. Lammert we published in Nature Communication that the myeloid-derived growth factor (MYDGF) is a mechanically induced angiocrine signal that induces growth and protection of primary mouse and human hepatocytes.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung